CPU upside is real but more cyclical than structural versus memory; AI demand is still fundamentally bandwidth- and capacity-driven, keeping HBM and advanced DRAM in a tighter supply-demand regime than CPUs, where competition and pricing pressure persist. For Intel, a new ATH is possible but contingent on sustained foundry traction, execution on advanced nodes, and credible AI accelerator share—none are fully de-risked yet. A $100 target implies multiple expansion plus earnings inflection that likely needs several quarters of flawless delivery. CPUs won’t replace memory as the “hot” leg; they may participate, but memory remains the higher-beta AI lever near term.
Intel Explodes on Terafab & Apple Deal! Did You Sell Too Early?
Intel surged 12.92% to $110.
Reports of Apple entering foundry negotiations with Intel Foundry, and Intel joining Elon Musk's Terafab chip manufacturing consortium.
An Apple foundry contract, if confirmed, would provide Intel Foundry with its most significant external customer endorsement, marking what analysts call a critical milestone in the new management team's strategic transformation. With three catalysts igniting on the same day, how is Intel's turnaround story different this time — and did you sell too early?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments